Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain
- PMID: 1310438
- PMCID: PMC358223
- DOI: 10.1128/CMR.5.1.49
Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain
Abstract
Studies of the pathogenesis and molecular biology of JC virus infection over the last two decades have significantly changed our understanding of progressive multifocal leukoencephalopathy, which can be described as a subacute viral infection of neuroglial cells that probably follows reactivation of latent infection rather than being the consequence of prolonged JC virus replication in the brain. There is now sufficient evidence to suggest that JC virus latency occurs in kidney and B cells. However, JC virus isolates from brain or kidney differ in the regulatory regions of their viral genomes which are controlled by host cell factors for viral gene expression and replication. DNA sequences of noncoding regions of the viral genome display a certain heterogeneity among isolates from brain and kidney. These data suggest that an archetypal strain of JC virus exists whose sequence is altered during replication in different cell types. The JC virus regulatory region likely plays a significant role in establishing viral latency and must be acted upon for reactivation of the virus. A developing hypothesis is that reactivation takes place from latently infected B lymphocytes that are activated as a result of immune suppression. JC virus enters the brain in the activated B cell. Evidence for this mechanism is the detection of JC virus DNA in peripheral blood lymphocytes and infected B cells in the brains of patients with progressive multifocal leukoencephalopathy. Once virus enters the brain, astrocytes as well as oligodendrocytes support JC virus multiplication. Therefore, JC virus infection of neuroglial cells may impair other neuroglial functions besides the production and maintenance of myelin. Consequently our increased understanding of the pathogenesis of progressive multifocal leukoencephalopathy suggests new ways to intervene in JC virus infection with immunomodulation therapies. Perhaps along with trials of nucleoside analogs or interferon administration, this fatal disease, for which no consensus of antiviral therapy exists, may yield to innovative treatment protocols.
Similar articles
-
Amplification of JC virus DNA from brain and cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy.Neurology. 1991 Dec;41(12):1967-71. doi: 10.1212/wnl.41.12.1967. Neurology. 1991. PMID: 1660572
-
Increased frequency of JC virus type 2 and of dual infection with JC virus type 1 and 2 in Italian progressive multifocal leukoencephalopathy patients.J Neurovirol. 2001 Feb;7(1):35-42. doi: 10.1080/135502801300069638. J Neurovirol. 2001. PMID: 11519480 Clinical Trial.
-
New insights into progressive multifocal leukoencephalopathy.Curr Opin Neurol. 2004 Jun;17(3):365-70. doi: 10.1097/00019052-200406000-00019. Curr Opin Neurol. 2004. PMID: 15167073 Review.
-
JC virus quasispecies analysis reveals a complex viral population underlying progressive multifocal leukoencephalopathy and supports viral dissemination via the hematogenous route.J Virol. 2015 Jan 15;89(2):1340-7. doi: 10.1128/JVI.02565-14. Epub 2014 Nov 12. J Virol. 2015. PMID: 25392214 Free PMC article.
-
Traffic of JC virus from sites of initial infection to the brain: the path to progressive multifocal leukoencephalopathy.J Infect Dis. 2002 Dec 1;186 Suppl 2:S180-6. doi: 10.1086/344280. J Infect Dis. 2002. PMID: 12424695 Review.
Cited by
-
The oncogenic roles of JC polyomavirus in cancer.Front Oncol. 2022 Sep 23;12:976577. doi: 10.3389/fonc.2022.976577. eCollection 2022. Front Oncol. 2022. PMID: 36212474 Free PMC article. Review.
-
The polyomaviruses WUPyV and KIPyV: a retrospective quantitative analysis in patients undergoing hematopoietic stem cell transplantation.Virol J. 2012 Sep 18;9:209. doi: 10.1186/1743-422X-9-209. Virol J. 2012. PMID: 22988938 Free PMC article.
-
Fatal PML associated with efalizumab therapy: insights into integrin αLβ2 in JC virus control.Neurology. 2012 Feb 14;78(7):458-67; discussion 465. doi: 10.1212/WNL.0b013e3182478d4b. Epub 2012 Feb 1. Neurology. 2012. PMID: 22302546 Free PMC article.
-
Analysis of minimal sequences on JC virus VP1 required for capsid assembly.J Neurovirol. 2001 Aug;7(4):298-301. doi: 10.1080/13550280152537139. J Neurovirol. 2001. PMID: 11517406 Review.
-
Rearrangement of simian virus 40 regulatory region is not required for induction of progressive multifocal leukoencephalopathy in immunosuppressed rhesus monkeys.J Virol. 2005 Feb;79(3):1361-6. doi: 10.1128/JVI.79.3.1361-1366.2005. J Virol. 2005. PMID: 15650162 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical